Embecta Corp.
Embecta Corp. (EMBC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EMBC · as of Jun 8, 2026
Key Statistics
Explore Embecta Corp. Data
embc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 0.0%
The EMBC analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +47.93% upside from the current price of $3.38.
Competitors & Peers
embc competitorsEMBC
AQST
CDNA
EBS
EVH
MRVIStock Performance
Full HistoryAbout Embecta Corp.
Embecta Corp. a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, a…
what is embecta corp. · embc stock overview · embecta corp. company profile · who is embecta corp. ceo · embc NASDAQ · embecta corp. headquarters · embecta corp. business segments
About Stock Overview & Key Data
Embecta Corp. (EMBC) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 22, 2022. As of the latest trading session, EMBC stock price is $3.38, with a market capitalization of $200.5M. The stock has returned -65.89% over the past 12 months and -71.55% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Embecta Corp. stock is Hold, with an average 12-month price target of $5.00. In fiscal year 2025, Embecta Corp. reported revenue of $1.1B and net income of $95.4M. For detailed data — including Embecta Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Embecta Corp. (EMBC) stock price is $3.38. The stock is traded on NASDAQ under the ticker symbol EMBC. The 52-week range is $2.77 – $15.55.